This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Institut Gustave Roussy, National Institute of Health and Medical Research, Université Paris-Saclay. Active years: 2011-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 101 
2 out of 1,853 
1 out of 98 
Years Active: 2011-2021
Title: Fathia Mami-Chouaib: Innovator in Cancer Immunotherapy
Introduction
Fathia Mami-Chouaib is a notable inventor based in Bourg la Reine, France. She has made significant contributions to the field of cancer immunotherapy, holding a total of 3 patents. Her work focuses on the development of immunogenic peptides that can enhance anti-tumor responses.
Latest Patents
Among her latest patents are innovations related to immunogenic preprocalcitonin peptides. This invention involves combinations of peptides carrying T-cell epitopes of the antigen preprocalcitonin, which are presented by the Major Histocompatibility Complex (MHC). These peptides have potential applications in anti-tumor immunotherapy. Another significant patent is related to Preprocalcitonin antigen T epitopes, which are also presented by MHC I. These peptides can be utilized in cancer immunotherapy, showcasing her commitment to advancing medical science.
Career Highlights
Fathia has worked with prestigious institutions such as the Gustave Roussy Institute and the National Institute of Health and Medical Research. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Salem Chouaib and Soraya Rifal. Their collaborative efforts have furthered the understanding and development of immunotherapeutic strategies.
Conclusion
Fathia Mami-Chouaib is a pioneering inventor whose work in cancer immunotherapy is making a significant impact. Her innovative patents and collaborations highlight her dedication to improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile